Trials / Unknown
UnknownNCT01664013
The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Roongroj Bhidayasiri · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the impact of botulinum toxin treatment in quality of life(QoL) in cervical dystonia patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nuronox | Reconstituted Neuronox® is injected at a dose determined by the physician based upon his/her clinical experience with botulinum toxin.Actual dose and injection site should be adjusted individually considering the muscle mass, degree of spasticity, body weight, and response to any previous botulinum toxin injections. |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-10-01
- First posted
- 2012-08-14
- Last updated
- 2013-08-20
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01664013. Inclusion in this directory is not an endorsement.